User:LeanMassLars
Editor·9,182 edits·since 2024/11
LeanMassLars is an editor on PeptidePedia Wiki, editing since 2024 / 11.
This editor works mainly on adverse effects and clinical safety. Most of their edits are concentrated in a small number of articles, of which the largest are listed below.
Editing record
9,182Total edits
30Logged here
23Articles touched
2024/11Editing since
The record shown on this wiki covers the pages indexed in this editor's contributions. Their declared area of interest is adverse effects and clinical safety.
Most-edited pages
| Page | Edits by this editor | Total revisions | Share |
|---|---|---|---|
| Adverse effects of GLP-1 receptor agonists | 3 | 44 | 7% |
| Peptide aggregation | 3 | 37 | 8% |
| Weight regain after discontinuation | 2 | 33 | 6% |
| Amylin receptor agonist | 1 | 33 | 3% |
| Triple agonist | 1 | 30 | 3% |
| Qingdao Saber Technology Pharmaceutical | 1 | 28 | 4% |
| LEADER trial | 1 | 31 | 3% |
| Good manufacturing practice | 1 | 37 | 3% |
| Exenatide | 1 | 33 | 3% |
| Personal importation policy | 1 | 26 | 4% |
| Shanghai Sigma-Audley New Material Technology | 1 | 37 | 3% |
| Syringe dead space | 1 | 31 | 3% |
| Aspiration risk under anaesthesia | 1 | 26 | 4% |
| Janoshik Analytical | 1 | 33 | 3% |
Awards
Disclosure
This editor declares no financial or professional relationship with any organisation covered by PeptidePedia Wiki. Editors who do have such a relationship are required to disclose it here under Project:Conflict of interest.